A molecular level understanding of zinc activation of C-peptide and its effects on cellular communication in the bloodstream

Review of Diabetic Studies

Volumn 6, Issue 3, 2009, Pages 148-158

  Medawala, Wathsala ^a   McCahill, Patrick ^a   Giebink, Adam ^a   Meyer, Jennifer ^a   Ku, Chia Jui ^a   Spence, Dana M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

ATP; C peptide; Diabetes; Glucose; Nitric oxide; Platelets; Red blood cell; Signaling; Zinc

Indexed keywords

ADENOSINE TRIPHOSPHATE; C PEPTIDE; GLUCOSE; METFORMIN; NITRIC OXIDE; ZINC;

CELL COMMUNICATION; ENDOTHELIUM CELL; ERYTHROCYTE; GLUCOSE TRANSPORT; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; THROMBOCYTE ADHESION;

EID: 76149123566     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2009.6.148     Document Type: Review

References (60)

1. Venkat NK, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden. Diabetes Care 2006. 29(9):2114-2115.
2. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections by 2010. Diabet Med 1997. 14:S5-S85.
3. Davidson HW, Rhodes CJ, Hutton JC. Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic cell via two distinct site-specific endopeptidases. Nature 1988. 333:93-96.
4. Rubenstein AH, Clark JL, Melani F, Steiner DF. Secretion of proinsulin c-peptide by pancreatic b cells and its circulation in blood. Nature 1969. 224(5220):697-699.
5. Johansson BL, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med 2000. 17(3):181-189.
6. Johansson BL, Kernell A, Sjoberg S, Wahren J. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocr Metab 1993. 77(4):976-981.
7. Johansson BL, Sjoeberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 1992. 35(2):121-128.
8. Rebsomen L, Pitel S, Boubred F, Buffat C, Feuerstein JM, Raccah D, Vague P, Tsimaratos M. C-peptide replacement improves weight gain and renal function in diabetic rats. Diabetes Metab 2006. 32(3):223-228.
9. Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Sjoquist M. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int 2001. 60(4):1258-1265.
10. Sjoquist M, Huang W, Johansson BL. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 1998. 54(3):758-764.
11. Forst T, Kunt T, Pohlmann T, Goitom K, Engelbach M, Beyer J, Pfutzner, A. Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus. J Clin Invest 1998. 101(10):2036-2041.
12. Stevens M, Zhang W, Li F, Sima AA. C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats. Am J Physiol Endocrinol Metab 2004. 287(3):E497:E505.
13. Ido Y, Vindigni A, Chang K, Stramm L, Chance R, Heath WF, DiMarchi RD, Di Cera E, Williamson JR. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 1997. 277(5325):563-566.
14. Zhang W, Kamiya H, Ekberg K, Wahren J, Sima AA. C-peptide improves neuorpathy in type 1 diabetic BB/Wor rats. Diabetes Metab Res 2007. 23:63-70.
15. Kunt T, Schneider S, Pfutzner A, Goitum K, Engelbach M, Schauf B, Beyer J, Forst T. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with type I diabetes mellitus. Diabetologia 1999. 42(4):465-471.
16. Hach T, Forst T, Kunt T, Ekberg K, Pfutzner A, Wahren J. C-peptide and its C-Terminal fragments improve erythrocyte deformability in type 1 diabetes patients. Exp Diabetes Res 2008. 2008:730594.
17. Meyer JA, Froelic JM, Reid GE, Karunarathne W, Spence DM. Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter. Diabetologia 2008. 51(1):175-182.
18. Meyer JA, Subasinghe W, Sima AA, Keltner Z, Reid GE, Daleke D, Spence DM. Zinc-activated C-peptide resistance to the type 2 diabetic erythrocyte is associated with hyperglycemia-induced phosphatidylserine externalization and reversed by metformin. Mol Biosyst 2009. 5:1157-1162.
19. Hutton JC. The internal pH and membrane potential of the insulin-secretory granule. Biochem J 1982. 204(1):171-8.
20. Kennedy RT, Huang L, Aspinwall CA. Extracellular pH is required for rapid release of insulin from Zn-insulin precipitates in beta-cell secretory vesicles during exocytosis. J Am Chem Soc 1996. 118(7):1795-1796.
21. Shafqat J, Melles E, Sigmundsson K, Johansson BL, Ekberg K, Alvelius G, Henriksson M, Johansson J, Wahren J, Joernvall H. Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects. Cell Mol Life Sci 2006. 63:1805-1811.
22. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980. 288:373-376.
23. Ignarro LJ, Buga G, Dhaudhuri G. EDRF generation and release from perfused bovine pulmonary artery and vein. Eur J Pharmacol 1988. 149:79-88.
24. Palmer R, Ferrige MJ, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxation factor. Nature 1987. 327:524-526.
25. Buga GM, Gold ME, Fukuto JM, Ignarro LJ. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 1991. 17:187-193.
26. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-nduced release of endothelium-derived relaxing factor. Am J Physiol 1986. 250:H1145-H1149.
27. Sprague RS, Stephenson AH, Dimmit RA, Weintraub NA, Branch CA, McMurdo L, Lonigro AJ. Effect of L-NAME on pressure-flow relationships in isolated rabbit lungs: Role of red blood cells. Am J Physiol 1995. 296:H1941-H1948.
28. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. ATP: the red blood cell link to NO and local control of the pulmonary circulation. Am J Physiol 1996. 271:H2717-H2722.
29. Dull RO, Tarbell JM, Daves PF. Mechanism of flow-mediated signal transduction in endothelial cells: kinetics of ATP surface concentrations. J Vasc Res 1992. 29:410-419.
30. Bogle RG, Coade SB, Moncada S, Pearson JD, Mann GE. Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem Biophys Res Commun 1991. 80:926-932.
31. Bergfeld GR, Forrester T. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnea. Cardiovasc Res 1992. 26:40-47.
32. Johansson BL, Wahren J, Pernow J. C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism. Am J Physiol Endocrinol Metab 2003. 285:E864-E870.
33. Hansen A, Johansson BL, Wahren J, Von Bibra H. C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes. Diabetes 2002. 51(10):3077-3082.
34. Li H, Xu L, Dunbar JC, Dhabuwala CB, Sima AA. Effects of C-peptide on expression of eNOS and iNOS in human cavernosal smooth muscle cells. Urology 2004. 64(3):622-627.
35. Collins DM, McCullough WT, Ellsworth ML. Conducted vascular responses: communication across the capillary bed. Microvasc Res 1998. 56:43-53.
36. Ellsworth ML, Forrester T, Ellis CG, Dietrich HH. The erythrocyte as a regulator of vascular tone. Am J Physiol 1995. 269:H2155-H2161.
37. McCullough WT, Collins DM, Ellsworth ML. Arteriolar responses to extracellular ATP in striated muscle. Am J Physiol 1997. 272:H1886-H1891.
38. Faris, AN, Spence DM. Measuring the simultaneous effects of hypoxia and deformation on ATP release from erythrocytes. Analyst 2008. 133(5):678-684.
39. Genes LI, Tolan NV, Hulvey MK, Martin RS, Spence DM. Adressing a vascular endothelium array with blood components using underlying microfluidic channels. Lab Chip 2007. 7(10):1256-1259.
40. Sprague RS, Ellsworth ML, Stephenson AH, Kleinhenz ME, Lonigro AJ. Deformation-induced ATP release from red blood cells requires cystic fibrosis transmembrane conductance regulator activity. Am J Physiol 1998. 275:H1726-H1732.
41. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. Increases in flow rate stimulate adenosine triphosphate release from red blood cells in isolated rabbit lungs. Exp Clin Cardiol 1998. 3:73-77.
42. Fischer DJ, Torrence NJ, Sprung RJ, Spence DM. Determination of erythrocyte deformability and its correlation to cellular ATP release using microbore tubing with diameters that approximate resistance vessels in vivo. Analyst 2003. 128:1163-1168.
43. Cao Z, Bell JB, Mohanty JG, Nagababu E, Rifkind JM. Nitrite enhances RBC hypoxic ATP synthesis and the release of ATP into the vasculature: a new mechanism for nitrite-induced vasodilation. Am J Physiol Heart Circ Physiol 2009. 297:H1494-H1503.
44. Olearczyk JJ, Stephenson AH, Lonigro AJ, Sprague RS. Receptor-mediated activation of the heterotrimeric G-protein Gs results in ATP release from erythrocytes. Med Sci Monit 2001. 7(4):669-674.
45. Olearczyk JJ, Stephenson AH, Lonigro AJ, Sprague RS. Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes. Am J Physiol 2004. 286(3, Pt. 2):H940-H945.
46. Sprague RS, Ellsworth ML, Stephenson AH, Lonigro AJ. Participation of cAMP in a signal-transuction pathway relating erythrocyte deformation to ATP release. Am J Physiol Cell Physiol 2001. 281(4):C1158-C1164.
47. Karunarathne W, Ku CJ, Spence DM. The dual nature of extracellular ATP as a concentration-dependent platelet P2X1 agonist and antagonist. Integrative Biology 2009.
48. Hu H, Li N, Ekberg K, Johansson BL, Hemjdahl P. Insulin, but not proinsulin C-peptide, enhances platelet fibrinogen binding in vitro in Type 1 diabetes mellitus patients and healthy subjects. Thromb Res 2002. 106(2):91-95.
49. Lindenblatt N, Braun B, Menger MD, Klar E, Vollmar B. C-peptide exerts antithrombotic effects that are repressed by insulin in normal and diabetic mice. Diabetologia 2006. 49(4):792-800.
50. Scalia R, Coyle KM, Levine BJ, Booth G, Lefer AM. C-peptide inhibits leukocyte-endothelium interaction in the microcirculation during acute endothelial dysfunction. FASEB J 2000. 14:2357-2364.
51. Sprague RS, Stephenson AH, Ellsworth ML, Keller C, Lonigro AJ. Impaired release of ATP from red blood cells of humans with primary pulmonary hypertension. Exp Biol Med 2001. 226(5):434-439.
52. Carroll JS, Subasinghe W, Raththagala M, Baguzis S, Oblak T, Root PD, Spence D. An altered erythrocyte pentose phosphate pathway affects the ability of red cells to release ATP, a nitric oxide stimulus. Mol Biosyst 2006. 2:305-311.
53. Sprague RS, Stephenson AH, Bowles EA, Stumpf MS, Lonigro AJ. Reduced expression of Gi in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release. Diabetes 2006. 55(12):3588-3593.
54. Spolarics Z, Condon MR, Siddiqi M, Machiedo GW, Deitch EA. Red blood cell dysfunction in septic glucose-6-phosphate dehydrogenase-deficient mice. Am J Physiol 2004. 286(6, Pt. 2):H2118-H2126.
55. Srour MA, Bilto YY, Juma M. Susceptibility of erythrocytes from non-insulin-dependent diabetes mellitus and hemodialysis patients, cigarette smokers and normal subjects to in vitro oxidative stress and loss of deformability. Clin Hemorheol Microcirc 2000. 22(3):173-180.
56. Jakus V. The role of nonenzymic glycation and glycosidation in the development of diabetic vascular complications. Cesk Psychol 2003. 52(2):51-65.
57. Ghigo D, Bosia A, Pagani A, Pescarmona GP, Pagano G, Lenti G. Changes in erythrocyte deformability resulting from alterations of redox metabolism in diabetes mellitus. Res Clin Lab 1983. 13(Suppl 3):375-381.
58. Cicha I, Tateishi N, Suzuki Y, Maeda N. Rheological changes in human red blood cells under oxidative stress: effects of thiol-containing antioxidants. Pathophysiology 1999. 6(2):121-128.
59. Carroll J, Ku CJ, Karunarathne W, Spence D. Red blood cell stimulation of platelet nitric oxide production indicated by quantitative monitoring of the communication between cells in the bloodstream. Anal Chem 2007. 79:5133-5138.
60. Ku CJ, D'Amico Oblak T, Spence DM. Interactions between multiple cell types in parallel microfluidic channels: Monitoring platelet adhesion to an endothelium in the presence of an anti-adhesion drug. Anal Chem 2008. 80(19):7543-7548.